NMRD (Nemaura Medical) Common Stock: $0.03 Mil (As of Dec. 2023)


What is Nemaura Medical Common Stock?

Nemaura Medical NMRD Common Stock is $0.03 Mil as of Dec. 2023.

Nemaura Medical's quarterly common stock stayed the same from Jun. 2023 ($0.03 Mil) to Sep. 2023 ($0.03 Mil) and stayed the same from Sep. 2023 ($0.03 Mil) to Dec. 2023 ($0.03 Mil).

Nemaura Medical's annual common stock increased from Mar. 2021 ($0.02 Mil) to Mar. 2022 ($0.02 Mil) and increased from Mar. 2022 ($0.02 Mil) to Mar. 2023 ($0.03 Mil).

Nemaura Medical Common Stock Historical Data

* Premium members only.

The historical data trend for Nemaura Medical's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nemaura Medical Common Stock Chart

Nemaura Medical Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.02 0.02 0.02 0.03

Nemaura Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.03 0.03 0.03

Nemaura Medical Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.03 Mil mean?
Nemaura Medical (NMRD) has a Common Stock of $0.03 Mil as of Dec. 2023. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Nemaura Medical and its competitors.
Is Nemaura Medical's Common Stock too high?
Nemaura Medical's current Common Stock is $0.03 Mil.
How does Nemaura Medical's Common Stock compare to THMO and MOTS?
Nemaura Medical's Common Stock of $0.03 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Nemaura Medical and its competitors. Nemaura Medical's current Common Stock is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nemaura Medical stock overvalued right now?
Nemaura Medical (NMRD) has a current Common Stock of $0.03 Mil. The current Common Stock is $0.03 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Nemaura Medical (NMRD), the current Common Stock is $0.03 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nemaura Medical Business Description

Address 57 West 57th Street, New York, NY, USA, 10019
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable, and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with an app displaying glucose readings at five-minute intervals for periods up to 24 hours.